Cargando…
Immunopathogenesis of COVID-19 and early immunomodulators
The novel coronavirus disease 2019 (COVID-19) is spreading globally. Although its etiologic agent is discovered as severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), there are many unsolved issues in COVID-19 and other infectious diseases. The causes of different clinical phenotypes and i...
Autores principales: | Lee, Kyung-Yil, Rhim, Jung-Woo, Kang, Jin-Han |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Pediatric Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7374000/ https://www.ncbi.nlm.nih.gov/pubmed/32664709 http://dx.doi.org/10.3345/cep.2020.00759 |
Ejemplares similares
-
Kawasaki Disease: Laboratory Findings and an Immunopathogenesis on the Premise of a "Protein Homeostasis System"
por: Lee, Kyung-Yil, et al.
Publicado: (2012) -
Early preemptive immunomodulators (corticosteroids) for severe pneumonia patients infected with SARS-CoV-2
por: Lee, Kyung-Yil, et al.
Publicado: (2020) -
Common immunopathogenesis of central nervous system diseases: the protein-homeostasis-system hypothesis
por: Lee, Kyung-Yil
Publicado: (2022) -
A Common Immunopathogenesis Mechanism for Infectious Diseases: The Protein-Homeostasis-System Hypothesis
por: Lee, Kyung-Yil
Publicado: (2015) -
Hyperactive immune cells (T cells) may be responsible for acute lung injury in influenza virus infections: A need for early immune-modulators for severe cases
por: Lee, Kyung-Yil, et al.
Publicado: (2011)